Gene-targeted mice homozygous for a null mutation in lumican lum tm1sc /lum tm1sc in the CD-1 genetic background, and wild-type mice (CD1) were bred and housed at the Animal Resource Center, University of Texas Southwestern Medical Center (Dallas, TX). Handling of all animals conformed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. The study was divided into two separate experiments. In experiment 1 (normal corneal development), a total of 39 wild-type mice were killed at 1, 4, 8, 10, 12, 14, 20, and 30 days after birth to evaluate the normal development of the corneal stroma. In experiment 2 (stromal development in the lumican-deficient cornea) a total of 29 lumican-deficient mice and 33 age-matched wild-type mice were killed at 1, 2, 3, 4, 8, and 12 weeks after birth to evaluate the development of the corneal stroma in the lumican-deficient compared with the wild-type mouse. For both experiments, adult female animals were bred and dates of delivery recorded. At the specific times noted, neonatal mice were anesthetized with 100 mg/kg ketamine (Dodge Animal Health, Fort Dodge, IA) and 10 mg/kg xylazine (Akorn, Inc., Decatur, IL) by intraperitoneal injection. After induction of anesthesia, one eye of each mouse in experiment 1 and both eyes of each mouse in experiment 2 were evaluated by in vivo CM, as described in the next section, to measure epithelial and stromal thickness and quantify light-scattering. After in vivo CM, mice were humanely killed by cervical neck dislocation of the anesthetized animal. Eyes were then collected for laser scanning confocal analysis to measure density of keratocytes, using techniques to be described.